Extracellular matrix remodeling in the vascular wall

MP Jacob, C Badier-Commander, V Fontaine… - Pathologie …, 2001 - Elsevier
The extracellular matrix provides a structural framework essential for the functional
properties of vessel walls. The three dimensional organization of the extracellular matrix …

3-year clinical follow-up of the RIBS IV clinical trial: a prospective randomized study of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent …

F Alfonso, MJ Pérez-Vizcayno, J Cuesta… - JACC: Cardiovascular …, 2018 - jacc.org
Objectives: This study sought to compare the long-term safety and efficacy of drug-eluting
balloons (DEB) and everolimus-eluting stents (EES) in patients with in-stent restenosis (ISR) …

Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury

NA Scott - Advanced drug delivery reviews, 2006 - Elsevier
This review summarizes the restenotic process that occurs after the implantation of bare
metal coronary stents. The pathology of in-stent restenosis is distinct from that seen after …

Serial multimodality imaging and 2-year clinical outcomes of the novel DESolve novolimus-eluting bioresorbable coronary scaffold system for the treatment of single …

A Abizaid, RA Costa, J Schofer, J Ormiston… - JACC: Cardiovascular …, 2016 - jacc.org
Objectives: This study sought to report the late multimodality imaging and clinical outcomes
of the novel poly-l-lactic-acid–based DESolve novolimus-eluting bioresorbable coronary …

Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis

J Mehilli, RA Byrne, A Wieczorek, R Iijima… - European heart …, 2008 - academic.oup.com
Aims The objective of this study was to assess the non-inferiority, in terms of anti-restenotic
efficacy, of both biodegradable-polymer (BP) and polymer-free (PF) stents compared with …

Randomized multicenter trial investigating angiographic outcomes of hybrid sirolimus-eluting stents with biodegradable polymer compared with everolimus-eluting …

K Teeuwen, RJ van der Schaaf, T Adriaenssens… - JACC: Cardiovascular …, 2017 - jacc.org
Objectives: The aim of this study was to investigate the efficacy and safety of the hybrid
ultrathin-strut sirolimus-eluting stent (SES) with biodegradable polymer compared with the …

Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization

MJ Price, E Cristea, N Sawhney, JA Kao… - Journal of the American …, 2006 - jacc.org
Objectives: This study was performed to evaluate the clinical and serial angiographic
outcomes of patients undergoing sirolimus-eluting stent (SES) implantation for unprotected …

Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent …

J Hausleiter, A Kastrati, J Mehilli, M Vogeser… - Circulation, 2004 - Am Heart Assoc
Background—Despite recent advances in interventional cardiology, including the
introduction of drug-eluting stents for de novo coronary lesions, the treatment of in-stent …

A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon …

F Alfonso, MJ Pérez-Vizcayno, R Hernandez… - Journal of the American …, 2006 - jacc.org
Objectives: We sought to assess the effectiveness of sirolimus-eluting stents (SES) in
patients with in-stent restenosis (ISR). Background: Treatment of patients with ISR remains a …

Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents

GS Werner, A Krack, G Schwarz, D Prochnau… - Journal of the American …, 2004 - jacc.org
Objectives: The aim of this research was to assess the efficacy of paclitaxel-eluting stents in
chronic total coronary occlusions (CTO). Background: Percutaneous coronary interventions …